US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BlossomHill Therapeutics

20.86

-0.6500-3.02%

Volume:148.97K

Turnover:3.14M

Market Cap:639.23M

PE:-8.54

High:21.90

Open:21.55

Low:20.75

Close:21.51

52wk High:23.37

52wk Low:15.25

Shares:30.64M

Float Shares:9.38M

Volume Ratio:0.94

T/O Rate:1.59%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.4440

EPS(LYR):-24.8342

ROE:--

ROA:--

PB:-4.20

PE(LYR):-0.84

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Leerink Partners Initiates BlossomHill Therapeutics at Outperform, $36 Price Target

MT Newswires Live

BlossomHill Therapeutics to Present Updated Phase 1/2 Solara Trial Data on BH-30643 in EGFR-Mutant NSCLC at WCLC 2026

BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Cancer

BlossomHill Therapeutics Price Target Announced at $35.00/Share by HC Wainwright & Co.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BLSM"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BLSM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLSM\",,,,,undefined,":{"symbol":"BLSM","market":"US","secType":"STK","nameCN":"BlossomHill Therapeutics","latestPrice":20.86,"timestamp":1789156800000,"preClose":21.51,"halted":0,"volume":148974,"delay":0,"changeRate":-0.0302185030218504,"floatShares":9375000,"shares":30643700,"eps":-2.444,"marketStatus":"Pre-Mkt","change":-0.65,"latestTime":"09-14 04:06:43 EDT","open":21.55,"high":21.9,"low":20.75,"amount":3139098.1922999998,"amplitude":0.053464,"askPrice":32.55,"askSize":100,"bidPrice":8.36,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.444,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789392600000},"marketStatusCode":1,"adr":0,"listingDate":1786075200000,"exchange":"NASDAQ","adjPreClose":20.86,"postHourTrading":{"tag":"盘后","latestPrice":21.27,"preClose":20.86,"latestTime":"19:30 EDT","volume":109,"amount":2315.15,"timestamp":1789169407657,"change":0.41,"changeRate":0.019655,"amplitude":0.019655},"volumeRatio":0.9424797234212342},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLSM\",,,,,undefined,":{"symbol":"BLSM","floatShares":9375000,"roa":"--","roe":"--","lyrEps":-24.834182,"volumeRatio":0.9424797234212342,"shares":30643700,"dividePrice":0,"high":21.9,"amplitude":0.053464,"preClose":21.51,"low":20.75,"week52Low":15.25,"pbRate":"-4.20","week52High":23.37,"institutionHeld":0,"latestPrice":20.86,"eps":-2.444,"divideRate":0,"volume":148974,"delay":0,"ttmEps":-2.444,"open":21.55,"prevYearClose":16,"prevWeekClose":22.01,"prevMonthClose":18.3,"prevQuarterClose":16,"fiveDayClose":20.02,"twentyDayClose":16.35,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLSM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLSM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLSM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1788321600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BLSM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BLSM","date":"2026-09-11","current":-8.535188,"percent":0.12,"low":-9.884773,"twenty":-8.535478,"median":-7.091344,"eighty":-6.910289,"high":-2.788792,"avg":-7.593545,"sd":1.350613,"marketCap":659145126},"quantilePoints":[{"date":"2026-08-07","current":-6.897356,"twenty":-6.075643,"median":-4.843074,"eighty":-3.610505,"marketCap":490298560},{"date":"2026-08-14","current":-7.048236,"twenty":-7.038752,"median":-6.897356,"eighty":-6.893907,"marketCap":501023841},{"date":"2026-08-21","current":-6.811139,"twenty":-7.038752,"median":-6.955553,"eighty":-6.893907,"marketCap":484169828},{"date":"2026-08-28","current":-8.535478,"twenty":-7.10945,"median":-6.974951,"eighty":-6.897356,"marketCap":606744468},{"date":"2026-09-04","current":-8.630317,"twenty":-8.140605,"median":-7.054702,"eighty":-6.899943,"marketCap":613486073},{"date":"2026-09-11","current":-9.272633,"twenty":-8.535478,"median":-7.091344,"eighty":-6.910289,"marketCap":659145126}],"updateTime":1789373203396},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLSM\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664285564","title":"Leerink Partners Initiates BlossomHill Therapeutics at Outperform, $36 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2664285564","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664285564?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:24","pubTimestamp":1788261848,"startTime":"0","endTime":"0","summary":"Leerink Partners Initiates BlossomHill Therapeutics at Outperform, $36 Price Target","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664537848","title":"BlossomHill Therapeutics to Present Updated Phase 1/2 Solara Trial Data on BH-30643 in EGFR-Mutant NSCLC at WCLC 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664537848","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664537848?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:03","pubTimestamp":1788260634,"startTime":"0","endTime":"0","summary":"BlossomHill Therapeutics to present updated Phase 1/2 SOLARA trial data on BH-30643 in EGFR-mutant NSCLC at WCLC 2026BlossomHill flagged updated Phase 1/2 SOLARA data for BH-30643 in EGFR-mutant NSCLC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL406lNH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSM","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4007","IE00BQXX3F31.USD","IE00BN0W2W23.USD","LU0314104364.USD","BK4588","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","LU2210149790.SGD","BK4112","IE00BN0W2V16.EUR","LU2095319765.USD","NDAQ","SG9999014039.USD","IE00BQXX3C00.GBP","SG9999014013.SGD","SG9999014021.USD","IE00BKPKM429.USD","SG9999014005.SGD","IE00B64PRP62.GBP","BCDF","LU2210150020.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853002","title":"BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853002","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664853002?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"Data to be presented in a mini-oral session will describe anti-tumor activity of BH-30643 in patients with secondary EGFR resistance mutations such as EGFR C797S BH-30643 was recently granted Fast Tra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353953/0/en/blossomhill-therapeutics-to-present-updated-data-from-ongoing-phase-1-2-solara-trial-of-its-macrocyclic-omni-egfr-inhibitor-bh-30643-in-egfr-mutant-nsclc-at-the-2026-world-conferen.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853384","title":"BlossomHill Therapeutics Price Target Announced at $35.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853384","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664853384?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:42","pubTimestamp":1788259320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BLSM/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BLSM\",params:#limit:6,delay:false,,,undefined,":[]}}